| Abacavir Sulfate | 🇺🇸United States | 20MG, 20MG BASE/ML | solution | Marketed | Hetero Labs LTD III |
| Abacavir Sulfate | 🇺🇸United States | 300MG, 300MG BASE, 60 MG … | tablet | Marketed | Mylan Pharms INC |
| Abacavir Sulfate and LamivudineCombination | 🇺🇸United States | 600MG BASE; 300MG | tablet | Marketed | Aurobindo Pharma LTD |
| Abacavir Sulfate and LamivudineCombination | 🇺🇸United States | 60MG BASE; 30MG | tablet, for suspension | Not marketed | Pharmobedient |
| Abacavir; LamivudineCombination | 🇺🇸United States | 60MG; 30MG | tablet | Tentative approval | Hetero Labs LTD V |
| Abacavir and LamivudineCombination | 🇺🇸United States | 120MG; 60MG | tablet | Tentative approval | Mylan Labs LTD |
| Abacavir and LamivudineCombination | 🇺🇸United States | 120MG; 60MG | tablet, for suspension | Tentative approval | Cipla Limited |
| Abacavir Sulfate, Lamivudine and ZidovudineCombination | 🇺🇸United States | 300MG BASE; 150MG; 300MG | tablet | Tentative approval | Lupin |
| Abacavir Sulfate; LamivudineCombination | 🇺🇸United States | 60MG; 30MG | tablet, for suspension | Tentative approval | Cipla Limited |
| Abacavir Sulfate; LamivudineCombination | 🇺🇸United States | 600MG; 300MG, 60MG; 30MG | tablet | Tentative approval | Mylan Labs |
| Abacavir, Dolutegravir, LamivudineCombination | 🇺🇸United States | 300MG, 50MG | tablet | Tentative approval | Cipla Limited |
| Abacavir || Dolutegravir || LamivudineCombination | 🇺🇸United States | 300MG, 50MG, 600MG | tablet | Tentative approval | Emcure Pharms LTD |
| Abacavir; Dolutegravir; LamivudineCombination | 🇺🇸United States | 30MG, 5MG, 600MG; 50MG; 300MG … | tablet | Tentative approval | Laurus Labs LTD |
| Abacavir, Dolutegravir and LamivudineCombination | 🇺🇸United States | 30MG, 5MG | tablet | Tentative approval | Macleods Pharmaceuticals LTD |
| TriumeqCombination | 🇺🇸United States | 600MG BASE; 50MG BASE; 300MG | tablet | Marketed | Viiv Hlthcare |
| Triumeq PDCombination | 🇺🇸United States | 60MG BASE; 5MG BASE; 30MG | tablet, for suspension | Marketed | Viiv Hlthcare |
| Ziagen | 🇺🇸United States | 20MG BASE/ML | solution | Marketed | Viiv Hlthcare |
| TrizivirCombination | 🇺🇸United States | 300MG BASE; 150MG; 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Viiv Hlthcare |
| EpzicomCombination | 🇺🇸United States | 600MG BASE; 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Viiv Hlthcare |
| Ziagen | 🇺🇸United States | 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Viiv Hlthcare |
| Lamivudine; Zidovudine; AbacavirCombination | 🇺🇸United States | 150MG; 300MG; 300MG | tablet | Tentative approval | Aurobindo Pharma LTD |
| Dolutegravir Sodium and Abacavir Sulfate and LamivudineCombination | 🇺🇸United States | 300MG, 600MG | tablet | Tentative approval | Cipla Limited |
| EpzicomCombination | 🇺🇸United States | 600MG; 300MG | tablet | Tentative approval | Mylan Pharms INC |